BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6644441)

  • 1. Cefoperazone pharmacokinetics in acute childhood meningitis.
    Chartrand SA; Marks MI; Johnston JT; Frederick DF; Scribner RK
    J Pediatr; 1983 Dec; 103(6):991-5. PubMed ID: 6644441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftriaxone kinetics and cerebrospinal fluid penetration in infants and children with meningitis.
    Nahata MC; Durrell DE; Barson WJ
    Chemotherapy; 1986; 32(2):89-94. PubMed ID: 3698727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of cefoperazone in full-term and premature neonates.
    Rosenfeld WN; Evans HE; Batheja R; Jhaveri RC; Vohra K; Khan AJ
    Antimicrob Agents Chemother; 1983 Jun; 23(6):866-9. PubMed ID: 6225389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cefoperazone with penicillin, ampicillin, gentamicin, and chloramphenicol in the therapy of experimental meningitis.
    Scheld WM; Brodeur JP; Sande MA; Alliegro GM
    Antimicrob Agents Chemother; 1982 Oct; 22(4):652-6. PubMed ID: 6217785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefoperazone in newborn infants.
    Philips JB; Braune K; Ravis W; Cassady G; Dillon H
    Pediatr Pharmacol (New York); 1984; 4(3):193-7. PubMed ID: 6493842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cefoperazone after single and multiple doses.
    Ripa S; La Rosa F; Dainelli B; Ecari U; Ruffilli MP
    Int J Clin Pharmacol Res; 1986; 6(2):171-5. PubMed ID: 3721648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of cefuroxime in infants and children with bacterial meningitis.
    del Rio Mde L; Chrane DF; Shelton S; McCracken GH; Nelson JD
    Antimicrob Agents Chemother; 1982 Dec; 22(6):990-4. PubMed ID: 7159072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetration and clearance of cefoperazone and moxalactam in pleural fluid.
    Yamada H; Iwanaga T; Nakanishi H; Yamaguchi M; Iida K
    Antimicrob Agents Chemother; 1985 Jan; 27(1):93-5. PubMed ID: 3985598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentrations of cefoperazone in cerebrospinal fluid during bacterial meningitis.
    Cable D; Overturf G; Edralin G
    Antimicrob Agents Chemother; 1983 May; 23(5):688-91. PubMed ID: 6223578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential value of cefoperazone in bacterial meningitis: experimental studies.
    Durack DT; Perfect JR
    Drugs; 1981; 22 Suppl 1():60-4. PubMed ID: 6269824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug concentrations in the serum and cerebrospinal fluid of patients treated with cefoperazone/sulbactam after craniotomy.
    Wang Q; Wu Y; Chen B; Zhou J
    BMC Anesthesiol; 2015; 15():33. PubMed ID: 25798070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology and cerebrospinal fluid penetration of moxalactam in children and dosage recommendations.
    Kaplan SL; Mason EO; Kvernland SJ; Calaway EL; Feigin RD
    Rev Infect Dis; 1982; 4 Suppl():S597-602. PubMed ID: 6218570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fundamental and clinical studies of sulbactam/cefoperazone in the pediatric field].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Ishimoto K; Tominaga K
    Jpn J Antibiot; 1984 Oct; 37(10):1898-918. PubMed ID: 6094868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study of pharmacokinetics of cefoperazone in children].
    Bégué P; Quiniou F; Lasfargues G; Gaillard C; Safran C
    Pathol Biol (Paris); 1983 May; 31(5):366-9. PubMed ID: 6353326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The penetration of cefoperazone into the cerebrospinal fluid in patients on acute or chronic stage].
    Honda E; Shimamoto H; Hara K; Nishio N
    Jpn J Antibiot; 1988 Apr; 41(4):409-14. PubMed ID: 3404651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fundamental and clinical studies of sulbactam/cefoperazone in the pediatric field].
    Iwata S; Sato Y; Iwasaki Y; Hayano S; Wakabayashi R; Kojima Y; Akita H; Sunakawa K; Oikawa T; Osano M
    Jpn J Antibiot; 1984 Oct; 37(10):1831-45. PubMed ID: 6094863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefoperazone therapy of bacterial meningitis: a clinical trial.
    Cristiano P; Pempinello R; Iovene MR; Coppola L; Altucci P
    Infection; 1989; 17(6):378-81. PubMed ID: 2693358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Basic and clinical studies of sulbactam/cefoperazone in pediatric field].
    Haruta T; Ohkura K; Kuroki S; Kobayashi Y
    Jpn J Antibiot; 1984 Oct; 37(10):1893-7. PubMed ID: 6094867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on sulbactam/cefoperazone in the field of pediatrics].
    Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
    Jpn J Antibiot; 1984 Oct; 37(10):1859-79. PubMed ID: 6094865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical studies of cefoperazone in neurosurgery].
    Kitamura K; Shimizu T; Abe H; Suzuki J; Tanaka R; Nagai H; Yamamoto S; Handa H; Nishimoto A; Matsuoka K
    Jpn J Antibiot; 1986 Jan; 39(1):63-74. PubMed ID: 2939268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.